Corealis Pharma will be attending the Advancing Drug Development Forum (ADDF) 2026, taking place December 10th, 2026 in Cambridge, Massachusetts.

ADDF brings together biotech leaders, CMC experts, investors, and drug development professionals for candid conversations at the intersection of science, strategy, and execution. The forum focuses on real-world challenges shaping the future of drug development, from biotech leadership and development timelines to clinical readiness, emerging technologies, and smarter partnership models.

David Leroux-Petersen and David Kwajewski will be attending on behalf of Corealis and look forward to connecting with innovators advancing complex development programs. With expertise in oral solid dose formulation, analytical services, GMP clinical manufacturing, and clinical supply, Corealis helps sponsors navigate critical development milestones with confidence.

If you’ll be attending ADDF 2026, connect with the team to discuss your development goals and explore how Corealis can help advance your program from molecule to clinic.